October 17, 2018

Wednesday, October 17

5:00 – 6:00

Registration & Networking

6:00 – 6:10

Welcome and Opening Remarks

Bob Buderi, Xconomy
Anne Deconinck, Koch Institute for Integrative Cancer Research

6:10 – 6:40

The Beam Therapeutics Story

Beam is turning a new and precise CRISPR gene editing system, called base editing, into human medicines.

Introduction by Teresa Lavoie, Fish & Richardson
David Liu, Beam Therapeutics; Broad Institute of MIT & Harvard
John Evans, Beam Therapeutics

6:45 – 7:15

The Arrakis Therapeutics Story

Arrakis aims to target disease-causing RNA with small-molecule drugs.

Introduction by Adam Long, Scientist.com
Jennifer Petter, Arrakis Therapeutics
Michael Gilman, Arrakis Therapeutics

7:15 – 7:45

The Celsius Therapeutics Story

Celsius is using machine learning to mine the genetic blueprint of individual cells and find new drug targets.

Aviv Regev, Celsius Therapeutics; Broad Institute of MIT & Harvard
Christoph Lengauer, Celsius Therapeutics
Alexis Borisy, Celsius Therapeutics; Third Rock Ventures

7:45 – 8:45

Networking Reception

Please note that this schedule is subject to change.